House Commerce FDA reform bill markup expected by mid-July.
This article was originally published in The Rose Sheet
Executive Summary
HOUSE COMMERCE FDA REFORM BILL MARKUP EXPECTED BY MID-JULY with the goal of having legislation through the House in time for conference before Congress' summer recess, set to begin Aug. 2. The Senate FDA Reform/Prescription Drug User Fee Act reauthorization bill (S 830) was reported out of the Senate Labor Committee June 18 ("The Rose Sheet" June 23, p. 12).